ACI-19626

N/A

Report date: 2025/04/20 20:00:03

Base Information

Drug NameACI-19626
Drug Alias NameACI-19626[18F]ACI-19626
ClassificationRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo) > Radionuclide Imaging agent
Mechanisms of ActionPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsTDP-43 ProteinopathiesAmyotrophic Lateral SclerosisFrontotemporal Dementia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAc Immune Sa
China Registration ClassN/A

Develop Information

Active CompaniesAc Immune Sa
Inactive CompaniesN/A
Active IndicationsTDP-43 ProteinopathiesAmyotrophic Lateral SclerosisFrontotemporal Dementia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A